Across TCGA pan-cancer cohorts, ST13P11 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated ST13P11 data layer.
The strongest signal is observed in stomach adenocarcinoma (STAD), where higher ST13P11 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated ST13P11 expression acts as an unfavorable survival marker, although some lineages such as ESCA and CHOL show a favorable association.
STAD, SARC, and KIRP are the cancer types where ST13P11 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.